Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$418,894,035
+$85,912,931 QoQ
Shares Held
1,664,656
+8.7% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#92
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AVIVA PLC holds $4,883,087,810 across 10 Drug Manufacturers - General names. ABBV ranks #5 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
10,899,700 | $2,066,801,114 | |
| 2 | LLY |
ELI LILLY & Co
|
718,261 | $861,503,863 | |
| 3 | JNJ |
Johnson & Johnson
|
2,162,709 | $549,263,204 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,264,106 | $419,437,621 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
1,664,656 | $418,894,035 | |
| 6 | AMGN |
Amgen Inc
|
471,664 | $170,798,967 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,183,858 | $149,568,619 | |
| 8 | PFE |
Pfizer Inc
|
4,977,327 | $119,854,034 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $418,894,035 | 1,664,656 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $332,981,104 | 1,531,018 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $339,550,077 | 1,486,061 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $325,676,291 | 1,406,566 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $245,485,234 | 1,322,515 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $256,463,375 | 1,224,052 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $169,506,075 | 953,889 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $184,761,300 | 935,595 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $157,184,701 | 916,422 | Shares | Defined | 2024-08-02 | |
| 2024-03-31 | $140,182,036 | 769,808 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $114,552,584 | 739,192 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $109,530,629 | 734,809 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $95,099,305 | 705,851 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $92,761,149 | 582,049 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $104,295,498 | 645,353 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $73,599,019 | 548,387 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $89,129,624 | 581,938 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $77,353,704 | 477,168 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $75,337,237 | 556,405 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $69,546,916 | 644,729 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $73,799,925 | 655,184 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $68,030,337 | 628,630 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $88,338,209 | 824,435 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $74,171,561 | 846,804 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $85,761,799 | 873,516 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $42,389,677 | 556,368 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||